Myostatin is a procachectic growth factor during postnatal myogenesis

C McFarlane, M Sharma… - Current Opinion in Clinical …, 2008 - journals.lww.com
As myostatin is a potent inducer of muscle wasting, antagonists to myostatin have been
speculated to have great therapeutic value in alleviating muscle wasting. Indeed, myostatin …
被引用次数：38 相关文章

[引用][C] Myostatin is a procachectic growth factor during postnatal myogenesis

C McFarlane, M Sharma, R Kambadur - Current Opinion in Clinical …, 2008 - cir.nii.ac.jp
Myostatin is a procachectic growth factor during postnatal myogenesis | CiNii Research CiNii
国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …

Myostatin is a procachectic growth factor during postnatal myogenesis

C McFarlane, M Sharma, R Kambadur - 2008 - scholarbank.nus.edu.sg
PURPOSE OF REVIEW: To describe the most relevant recent observations concerning the
molecular mechanisms behind myostatin-induced muscle wasting. RECENT FINDINGS: The …

Myostatin is a procachectic growth factor during postnatal myogenesis

C McFarlane, M Sharma… - Current Opinion in …, 2008 - researchonline.jcu.edu.au
Purpose of review: To describe the most relevant recent observations concerning the
molecular mechanisms behind myostatin-induced muscle wasting. Recent findings: The …

Myostatin is a procachectic growth factor during postnatal myogenesis

C McFarlane, M Sharma… - Current opinion in …, 2008 - pubmed.ncbi.nlm.nih.gov
Purpose of review To describe the most relevant recent observations concerning the
molecular mechanisms behind myostatin-induced muscle wasting. Recent findings The …

Myostatin is a procachectic growth factor during postnatal myogenesis.

C McFarlane, M Sharma, R Kambadur - Current Opinion in Clinical …, 2008 - europepmc.org
As myostatin is a potent inducer of muscle wasting, antagonists to myostatin have been
speculated to have great therapeutic value in alleviating muscle wasting. Indeed, myostatin …

[引用][C] Myostatin is a procachectic growth factor during postnatal myogenesis

C MCFARLANE, M SHARMA… - Current opinion in …, 2008 - Lippincott Williams & Wilkins